New treatments to heal bone damage from cancer radiation therapy
Official title: Novel therapeutic approaches to remediate radiotherapy-induced bone necrosis
Funded at University of Pennsylvania · NIH-10912194 · Data updated 2026-11-12
This study is looking at new treatments to help heal bone damage in African-American patients with oropharyngeal cancer who have had radiation therapy, aiming to improve their recovery and overall health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 15, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $200,000 |
| NIH project number | 1R56CA283140-01 |
| Project ID | NIH-10912194 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African-American patients diagnosed with oropharyngeal cancer who are undergoing or have undergone radiotherapy.
✕Less likely to help
Patients who do not have oropharyngeal cancer or those who have not received radiotherapy may not benefit from this research.
What this research studies
This research focuses on developing innovative therapies to address osteoradionecrosis (ORN), a severe complication that affects patients with oropharyngeal cancer (OPC) after receiving radiotherapy. The study aims to evaluate the effectiveness of injectable osteoanabolic drugs in promoting bone healing specifically in African-American patients, who are at a higher risk for ORN due to lower levels of circulating progenitor cells. By understanding how these therapies can improve bone healing, the research seeks to enhance overall survival outcomes for patients suffering from OPC. The approach includes assessing the efficacy of these new treatments in a controlled setting to determine their potential benefits.
Why it matters
Potential benefit: If successful, this research could significantly improve bone healing and survival rates for patients with oropharyngeal cancer who experience complications from radiation therapy.
How similar studies have gone: Previous research has shown promise in using injectable therapies for bone healing, but this specific approach targeting ORN in African-American patients is relatively novel.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Akintoye, Sunday O — University of Pennsylvania
- Study coordinator: Akintoye, Sunday O
Related research
Other NIH-funded projects on the same topics.
-
AI-powered radiotherapy planning for cervical and head-and-neck cancer
A computer program helps plan radiation therapy for cervical and head-and-neck cancer patients to make treatments faster and more accurate.
-
AI-powered radiotherapy planning for cervical and head-and-neck cancer
A United Kingdom study is testing AI software that helps plan radiotherapy for cervical and head-and-neck cancer patients to save time and reduce the workload for clinicians in low-resource settings.
-
AI-powered radiotherapy planning for cervical and head-and-neck cancer
A UK research team is testing an AI-based software to automatically outline cancer areas and plan radiation beams to speed up treatment for cervical and head-and-neck cancers in LMICs.
-
AI-Powered Radiotherapy Planning for Cervical and Head & Neck Cancer
A new AI tool helps plan radiation therapy for cervical and head-and-neck cancers to save time and reduce the need for specialized staff.
-
AI-powered radiotherapy planning for cervical and head-and-neck cancer
A UK study from University College London uses AI to plan radiotherapy for cervical and head-and-neck cancers to save time and reduce the need for specialized staff, aiming to help patients in LMICs.
-
AI-powered radiotherapy planning for cervical and head & neck cancer
A non-randomized study will test an AI system that helps plan radiotherapy for cervical and head & neck cancers to save time and resources in LMICs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.